Twinbeech Capital LP Abiomed Inc Transaction History

Twinbeech Capital LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$242.49 - $301.46 $1.56 Million - $1.94 Million	6,434 Added 116.75%	11,945 $2.93 Million
Q2 2022 Aug 15, 2022	BUY	$224.73 - $338.64 $1.24 Million - $1.87 Million	5,511 New	5,511 $1.36 Million
Q2 2021 Aug 16, 2021	SELL	$262.71 - $351.17 $1.53 Million - $2.05 Million	-5,834 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$285.92 - $355.13 $1.67 Million - $2.07 Million	5,834 New	5,834 $1.86 Million
Q3 2020 Nov 16, 2020	SELL	$255.22 - $317.0 $577,562 - $717,371	-2,263 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$141.4 - $257.09 $109,443 - $198,987	774 Added 51.98%	2,263 $547,000
Q1 2020 May 15, 2020	SELL	$130.51 - $196.01 $477,927 - $717,788	-3,662 Reduced 71.09%	1,489 $216,000
Q4 2019 Feb 14, 2020	BUY	$159.31 - $223.54 $820,605 - $1.15 Million	5,151 New	5,151 $879,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.